Form 4: Encompass Health Director Greg Carmichael Receives Additional Stock Units from Dividend

Encompass Health Corp. Director Greg D. Carmichael was awarded 24 additional restricted stock units on July 15, 2025, as part of a dividend payment on the company's common stock.

Summary

• Greg D. Carmichael, a Director of Encompass Health Corp. (EHC), acquired 24 additional restricted stock units (RSUs).
• This acquisition occurred on July 15, 2025, and was an award, not a purchase, with a transaction price of $0.
• The RSUs were credited to his account in connection with a common stock dividend payment.
• On July 15, 2025, Encompass Health paid a dividend of $0.17 per share.
• The closing price of Encompass Health common stock on the dividend payment date was $107.28.
• Following this transaction, Greg D. Carmichael beneficially owns 18,608 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It's a routine compensation event for a director, indicating continued alignment with shareholder interests through equity awards. No negative implications are present.

Positives

• Director Greg D. Carmichael's beneficial ownership increased by 24 shares, reflecting continued alignment with shareholder interests.
• The award of restricted stock units is a standard component of non-employee director compensation, linking their incentives to company performance and dividends.

Negatives

• No specific negative aspects are indicated in this routine insider transaction filing.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

This Form 4 filing reports a completed insider transaction and does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing details a routine insider transaction related to director compensation, specifically the award of restricted stock units tied to a dividend payment. Such compensation structures are common across various industries, including healthcare, to align director incentives with shareholder returns. It does not provide broader industry trends or competitive insights.

Comparison to Industry Standards

• This filing reports a standard mechanism for non-employee director compensation, where restricted stock units are awarded in lieu of or in addition to cash dividends, a practice common among publicly traded companies.
• Many S&P 500 companies utilize RSU awards as part of their director compensation packages to foster long-term alignment. Specific comparable companies or projects are not relevant for this type of individual transaction report.

Stakeholder Impact

• Shareholders: The award of RSUs to a director aligns their interests with shareholders, as the value of the RSUs is tied to the company's stock performance and dividend payments.

Next Steps

• No specific future actions, events, or milestones are mentioned in this Form 4 filing beyond the reported transaction.

Key Dates

Keywords

Encompass Health Corp, EHC, SEC Form 4, Insider Trading, Restricted Stock Units, RSU, Dividend, Director Compensation, Stock Award, Beneficial Ownership